Thursday, October 12, 2023 at 2-3 pm ET                 Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by chronic pelvic pain and infertility, that can have a significant impact in some patients on quality of life, function, and healthcare costs.  The total annual societal burden of endometriosis in the United States is estimated to be $69.4 billion, of which indirect and direct costs comprise 66% and 34%, respectively.  Endometriosis disease peaks at the most productive working- years and contributes to a loss of 1.1 hours per week of employment productivity because of absenteeism and an average loss of 5.3 hours per week due to presenteeism.  Therefore, early diagnosis and treatment is crucial for the best outcome and relief of symptoms. 

The objective of this webinar is to understand the burden of endometriosis and its impact on quality of life, which is essential to developing an individualized treatment approach to address each patient’s unique needs.  Additionally, we will review the current treatment landscape as well as data from a clinical trial program for endometriosis associated pain.

Learning Objectives

• Discuss the burden of disease and impact of symptomatic endometriosis on quality of life.
• Review economic and social impact of endometriosis.
• Review the diagnosis of endometriosis and the current treatment landscape for endometriosis associated pain.
• Understand the importance of an individualized treatment approach in the management of endometriosis associated pain.
• Review the development program behind Elagolix for moderate to severe endometriosis associated pain.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.